Jump to content

Main menu Navigation ●Main page ●Contents ●Current events ●Random article ●About Wikipedia ●Contact us ●Donate Contribute ●Help ●Learn to edit ●Community portal ●Recent changes ●Upload file

●Create account ●Log in ●Create account ● Log in Pages for logged out editors learn more ●Contributions ●Talk

(Top) 1 Contraindications 2 Pharmacokinetics 3 References

Gliquidone

●العربية ●فارسی ●Bahasa Indonesia ●Italiano ●Polski ●Română ●Српски / srpski ●Srpskohrvatski / српскохрватски ●Українська ●Tiếng Việt Edit links ●Article ●Talk ●Read ●Edit ●View history Tools Actions ●Read ●Edit ●View history General ●What links here ●Related changes ●Upload file ●Special pages ●Permanent link ●Page information ●Cite this page ●Get shortened URL ●Download QR code ●Wikidata item Print/export ●Download as PDF ●Printable version Appearance From Wikipedia, the free encyclopedia

Gliquidone
Clinical data

Trade names	Glurenorm
AHFS/Drugs.com	International Drug Names
Pregnancy category	C
Routes of administration	Oral (tablets)
ATC code	A10BB08 (WHO)
Legal status
Legal status	UK: POM (Prescription only) In general: ℞ (Prescription only)
Pharmacokinetic data
Bioavailability	High (T_max = 2–3 hours)
Metabolism	Extensive hepatic
Onset of action	1–1.5 hours
Excretion	Biliary (95%), renal (5%)
Identifiers
IUPAC name 1-cyclohexyl-3-[4-[2-(7-methoxy-4,4-dimethyl-1,3-dioxoisoquinolin-2-yl)ethyl]phenyl]sulfonylurea
CAS Number	33342-05-1
PubChem CID	91610
DrugBank	DB01251^Y
ChemSpider	82719^Y
UNII	C7C2QDD75P
KEGG	D02430^Y
ChEMBL	ChEMBL383634^Y
CompTox Dashboard (EPA)	DTXSID4023096
ECHA InfoCard	100.046.770
Chemical and physical data
Formula	C₂₇H₃₃N₃O₆S
Molar mass	527.64 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES O=C(NC1CCCCC1)NS(=O)(=O)c2ccc(cc2)CCN4C(=O)c3c(ccc(OC)c3)C(C4=O)(C)C
InChI InChI=1S/C27H33N3O6S/c1-27(2)23-14-11-20(36-3)17-22(23)24(31)30(25(27)32)16-15-18-9-12-21(13-10-18)37(34,35)29-26(33)28-19-7-5-4-6-8-19/h9-14,17,19H,4-8,15-16H2,1-3H3,(H2,28,29,33)^Y Key:LLJFMFZYVVLQKT-UHFFFAOYSA-N^Y
(verify)

Gliquidone (INN, sold under the trade name Glurenorm) is an anti-diabetic medication in the sulfonylurea class.^[1] It is classified as a second-generation sulfonylurea. It is used in the treatment of diabetes mellitus type 2. It is marketed by the pharmaceutical company Boehringer Ingelheim (Germany).

Contraindications[edit]

Allergy to sulfonylureas or sulfonamides
Diabetes mellitus type 1
Diabetic ketoacidosis
Patients that underwent removal of the pancreas
Acute porphyria
Severe liver disease accompanying with liver insufficiency
Several conditions (e.g., infectious diseases or major surgical intervention), when insulin administration is required
Pregnancyorbreastfeeding^[2]

Pharmacokinetics[edit]

Gliquidone is fully metabolized by the liver. Its metabolites are excreted virtually completely with bile (even with long-term administration), thus allowing the use of medication in diabetic patients with kidney disease and diabetic nephropathy.^[2]